AVBP Arrivent Biopharma16.90+1.81 (+12.0%)
After Hours Decliner
AVBP Arrivent Biopharma15.09-13.37-47.0%
After Hours:14.80-0.29 (-1.9%)
ArriVent BioPharma Investigation Notice: Levi & Korsinsky Notifies Investors of Pending Investigation Into ArriVent BioPharma (AVBP)
PRNewswireTue, 6-Oct 5:48 PM
AVBP Arrivent Biopharma12.94-15.52 (-54.5%)
Premarket Decliner
AVBP Arrivent Biopharma28.46+0.19+0.7%
Premarket:10.80-17.66 (-62.1%)
ArriVent Announces Program Update from the Phase 3 FURVENT Trial of Firmonertinib in First-Line EGFR Exon 20 Insertion Mutant NSCLC
Globe NewswireTue, 6-Oct 8:00 AM
AVBP Arrivent Biopharma30.97+0.02 (+0.1%)
AVBP Arrivent Biopharma30.77-0.26 (-0.8%)
